خطوط تولید – English – شرکت نوا واکسن راد

Production lines

Nova Vaccine Rad Company was established in 2019.
With the aim of achieving self-sufficiency and independence of the poultry industry from imported vaccines and producing recombinant vaccines by adapting vaccine seeds to the country’s circulating strains with high quality, efficiency, and reasonable prices, this company began its activities in 1400 by producing highly pathogenic avian influenza vaccine and was able to supply 70 percent of the country’s need for highly pathogenic influenza vaccine in industrial poultry farms within one year.
Since 1403, it began producing and supplying the Newcastle dual influenza vaccine.
Also, by producing oil adjuvant for veterinary vaccines, it succeeded in exporting it abroad for the first time in Iran.

Production spaces:

Laboratories:

Intermediate and final product quality control laboratory
Animal Laboratory: Equipped with equipment such as dedicated isolators for use in product research and development and conducting vaccine potency and safety tests.

Quality standards:

Class B (Full Fresh) and converting it to Grade A by installing ceiling hoods: Units for antigen production, formulation, and final product filling are Grade B production sites that have full fresh full exhaust air handling units equipped with Grade A biological hoods.
Using industrial automation systems and taking advantage of their benefits in improving quality and reducing errors

Washing and sterilization methods:

Use of water for injection (WFI) and pure steam, focusing on their importance in maintaining product quality.

High quality products:

Benefits of Nova vaccines for poultry industry

Consistent with the latest field strains circulating in the country and middle East
Production according to World Organization for Animal Health (WOAH) GMP standards in the most modern and only reinforced level 2 biosafety infrastructure in the country currently in the field of poultry vaccines.
Having the optimal amount of antigen in all vaccines produced
Use of stable, low-viscosity, easy-to-inject oil adjuvant

Experience and technical knowledge:

Emphasis on the experience and expertise of the company’s technical team: Currently, 14 human resources with master’s and doctoral degrees are working in this company.

Quality control tests:

Summary of IPQC processes:
Tests performed on fertilized eggs (Mycoplasma test, SAN Test: Specific Antibody Negative, HA test)
Inactivation, sterility and Mycoplasma bulk antigen confirmation test
Tests conducted on bulk virus ready for formulation for production
HA test, sterility adjuvant, vaccine vial, cap and rubber stopper
collaboration with the Industry Relations Office of the Faculty of Veterinary Medicine, University of Tehran, partner laboratories of the Food and Drug Administration and the National Veterinary Organization.
Final approval: Given the importance of final approval of products before distribution, conducting the necessary tests on the vaccine (final product)